PUBLISHER: KBV Research | PRODUCT CODE: 1462064
PUBLISHER: KBV Research | PRODUCT CODE: 1462064
Asia Pacific HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030
The Asia Pacific HIV Injection Market would witness market growth of 18.7% CAGR during the forecast period (2023-2030).
The China market dominated the Asia Pacific HIV Injection Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $172.7 Million by 2029. The Japan market is registering a CAGR of 17.9% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 19.4% during (2023 - 2030).
HIV injections are an important treatment option for people living with HIV, offering several advantages over oral medications, including improved adherence, reduced risk of drug interactions, and potentially higher efficacy. In recent years, the market has expanded substantially, propelled by the escalating the prevalence of HIV/AIDS and the rising need for efficacious treatment alternatives.
Injectable HIV medications offer several advantages over oral medications, including improved adherence, reduced pill burden, and potentially better long-term outcomes. As a result, the demand for injectable HIV medications has been steadily increasing, driving growth in the market. Regarding the management of HIV/AIDS, patient adherence and preference are critical, and injectable treatments contribute significantly to resolving these concerns.
The demand in the Asia Pacific is likely to be influenced by the high number of people living with HIV in the region, as well as the efforts of governments and organizations to expand access to HIV prevention, testing, treatment, and care. According to a report by the Organisation for Economic Co-operation and Development (OECD), Asia ranks second in the prevalence of individuals living with HIV, behind only sub-Saharan Africa. These factors will, consequently, bolster the development of the regional market.
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F. Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
Asia Pacific HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1Asia Pacific HIV Injection Market, by Distribution Channel
- 1.4.2Asia Pacific HIV Injection Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Asia Pacific HIV Injection Market by Distribution Channel
- 4.1Asia Pacific Hospital Pharmacy Market by Country
- 4.2Asia Pacific Drugs Stores & Retail Pharmacies Market by Country
- 4.3Asia Pacific Others Market by Country
Chapter 5.Asia Pacific HIV Injection Market by Country
- 5.1China HIV Injection Market
- 5.1.1China HIV Injection Market by Distribution Channel
- 5.2Japan HIV Injection Market
- 5.2.1Japan HIV Injection Market by Distribution Channel
- 5.3India HIV Injection Market
- 5.3.1India HIV Injection Market by Distribution Channel
- 5.4South Korea HIV Injection Market
- 5.4.1South Korea HIV Injection Market by Distribution Channel
- 5.5Singapore HIV Injection Market
- 5.5.1Singapore HIV Injection Market by Distribution Channel
- 5.6Malaysia HIV Injection Market
- 5.6.1Malaysia HIV Injection Market by Distribution Channel
- 5.7Rest of Asia Pacific HIV Injection Market
- 5.7.1Rest of Asia Pacific HIV Injection Market by Distribution Channel
Chapter 6.Company Profiles
- 6.1GlaxoSmithKline PLC (GSK)
- 6.1.1Company Overview
- 6.1.2Financial Analysis
- 6.1.3Regional Analysis
- 6.1.4Research & Development Expense
- 6.1.5SWOT Analysis
- 6.1Gilead Sciences, Inc.
- 6.1.1Company overview
- 6.1.2Financial Analysis
- 6.1.3Research & Development Expenses
- 6.1.4SWOT Analysis
- 6.2ImmunityBio, Inc.
- 6.2.1Company Overview
- 6.2.2Financial Analysis
- 6.2.3Regional Analysis
- 6.2.4Research & Development Expenses
- 6.2.5SWOT Analysis
- 6.3F. Hoffmann-La Roche Ltd.
- 6.3.1Company Overview
- 6.3.2Financial Analysis
- 6.3.3Segmental and Regional Analysis
- 6.3.4Research & Development Expense
- 6.3.5SWOT Analysis
- 6.4Theratechnologies Inc.
- 6.4.1Company Overview
- 6.4.2Financial Analysis
- 6.4.3Research & Development Expenses
- 6.4.4SWOT Analysis
- 6.5Viriom, Inc.
- 6.5.1Company Overview
- 6.5.2SWOT Analysis
- 6.6AbbVie, Inc.
- 6.6.1Company Overview
- 6.6.2Financial Analysis
- 6.6.3Regional Analysis
- 6.6.4Research & Development Expense
- 6.6.5SWOT Analysis
- 6.7Brii Biosciences Limited
- 6.7.1Company Overview
- 6.7.2Financial Analysis
- 6.7.3Research & Development Expenses
- 6.7.4SWOT Analysis
- 6.8Shionogi & Co., Ltd.
- 6.8.1Company Overview
- 6.8.2Financial Analysis
- 6.8.3Research & Development Expenses
- 6.8.4SWOT Analysis
- 6.9Boehringer Ingelheim International GmbH
- 6.9.1Company Overview
- 6.9.2Financial Analysis
- 6.9.3Regional & Segmental Analysis
- 6.9.4Research & Development Expenses
- 6.9.5SWOT Analysis
LIST OF TABLES
- TABLE 1Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
- TABLE 2Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
- TABLE 3Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 4Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 5Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 6Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 7Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 8Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 9Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 10Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 11Asia Pacific HIV Injection Market by Country, 2019 - 2022, USD Million
- TABLE 12Asia Pacific HIV Injection Market by Country, 2023 - 2030, USD Million
- TABLE 13China HIV Injection Market, 2019 - 2022, USD Million
- TABLE 14China HIV Injection Market, 2023 - 2030, USD Million
- TABLE 15China HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 16China HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 17Japan HIV Injection Market, 2019 - 2022, USD Million
- TABLE 18Japan HIV Injection Market, 2023 - 2030, USD Million
- TABLE 19Japan HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 20Japan HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 21India HIV Injection Market, 2019 - 2022, USD Million
- TABLE 22India HIV Injection Market, 2023 - 2030, USD Million
- TABLE 23India HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 24India HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 25South Korea HIV Injection Market, 2019 - 2022, USD Million
- TABLE 26South Korea HIV Injection Market, 2023 - 2030, USD Million
- TABLE 27South Korea HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 28South Korea HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 29Singapore HIV Injection Market, 2019 - 2022, USD Million
- TABLE 30Singapore HIV Injection Market, 2023 - 2030, USD Million
- TABLE 31Singapore HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 32Singapore HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 33Malaysia HIV Injection Market, 2019 - 2022, USD Million
- TABLE 34Malaysia HIV Injection Market, 2023 - 2030, USD Million
- TABLE 35Malaysia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 36Malaysia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 37Rest of Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
- TABLE 38Rest of Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
- TABLE 39Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 40Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 41Key Information - GlaxoSmithKline PLC
- TABLE 42Key Information - Gilead Sciences, Inc.
- TABLE 43Key Information - ImmunityBio, Inc.
- TABLE 44Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 45Key Information - Theratechnologies Inc.
- TABLE 46Key Information - Viriom, Inc.
- TABLE 47Key information - AbbVie, Inc.
- TABLE 48Key Information - Brii Biosciences Limited
- TABLE 49Key Information - Shionogi & Co., Ltd.
- TABLE 50Key Information - Boehringer Ingelheim International GmbH
